Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : NABSE : 524731ISIN CODE : INE354A01013Industry : Pharmaceuticals & DrugsHouse : Private

BSE1329.2022.7 (+1.74 %)

PREV CLOSE ( ) 1306.50

OPEN PRICE ( ) 1308.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1731

TODAY'S LOW / HIGH ( )1299.15 1349.00

52 WK LOW / HIGH ( ) 815.81410

NSE

This Company is not listed in NSE

Chairman	Ashish U Bhuta
Managing Director	Ashish U Bhuta
Company Secretary	Ashish R Shah
Non Executive Independent Director	Hina R Mehta Sumit A Thakkar Krishnan Subharaman Pankaj A Dantwala
Whole Time Director	Dilip H Bhuta

Incorporation Year : 1985

Registered Office :

Address : Nirmala Apartments,93 Jayprakash Road,Andheri (West) Mumbai,
Maharashtra-400058 .

Phone : 022-67603603

Industry : Pharmaceuticals & Drugs

Listing : BSE